The Scientific Advisory Board comprises of a multidisciplinary team of experts in basic and clinical cancer research. They offer insight on critical and emerging global trends in biomedical research, identify promising channels for the institute to tap into and make recommendations that support its scientific goals.
CSI Singapore’s Scientific Advisory Board (SAB) comprises of experts coming from a multidisciplinary range of cancer research including basic and clinical studies. They support the Institute’s vision in becoming a premier cancer centre by providing recommendations and advice on the management, development and growth to the Board and Directors.